RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 112 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,775,352 | +247.4% | 43,238 | -15.5% | 0.00% | – |
Q4 2021 | $511,000 | -23.5% | 51,161 | 0.0% | 0.00% | – |
Q3 2021 | $668,000 | -33.3% | 51,161 | 0.0% | 0.00% | – |
Q2 2021 | $1,002,000 | -27.7% | 51,161 | -21.4% | 0.00% | – |
Q1 2021 | $1,385,000 | -70.8% | 65,108 | -59.2% | 0.00% | -100.0% |
Q4 2020 | $4,740,000 | +37.2% | 159,428 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $3,455,000 | -32.7% | 159,428 | -30.7% | 0.00% | 0.0% |
Q2 2020 | $5,133,000 | +46.5% | 230,195 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $3,504,000 | -33.7% | 230,195 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $5,285,000 | +463.4% | 230,195 | +667.3% | 0.00% | – |
Q2 2018 | $938,000 | -5.7% | 30,000 | -40.0% | 0.00% | – |
Q1 2018 | $995,000 | -31.5% | 50,000 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $1,453,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |